Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 10/08/2011
PIL Zoton FasTab

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 24/06/2011 and displayed until 10/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Change to MA holder contact details
Updated on 28/04/2011 and displayed until 24/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 14/08/2008 and displayed until 28/04/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 06/06/2008 and displayed until 14/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 25/09/2007 and displayed until 06/06/2008
Reasons for adding or updating:
  • Change to appearance of the medicine
Updated on 08/05/2007 and displayed until 25/09/2007
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 23/11/2006 and displayed until 08/05/2007
Reasons for adding or updating:
  • Change of licence holder
  • Change to date of revision
Updated on 18/09/2002 and displayed until 23/11/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   lansoprazole